Sirio Pharma Co., Ltd. (SHE:300791)
China flag China · Delayed Price · Currency is CNY
24.45
+0.08 (0.33%)
Sep 5, 2025, 3:04 PM CST

Sirio Pharma Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20 2017 - 2020
Operating Revenue
4,2494,1843,5682,4932,3312,029
Upgrade
Other Revenue
13.4927.413.9114.1938.0137.42
Upgrade
4,2624,2113,5822,5072,3692,067
Upgrade
Revenue Growth (YoY)
5.82%17.56%42.87%5.84%14.62%30.85%
Upgrade
Cost of Revenue
2,8952,8912,4981,7371,6041,405
Upgrade
Gross Profit
1,3671,3201,085770.42764.94661.56
Upgrade
Selling, General & Admin
834.4770.86628.44428.27385.27306.64
Upgrade
Research & Development
120.81125.94110.4980.7283.1964.71
Upgrade
Other Operating Expenses
-9.18-6.48-35.814.8514.412.82
Upgrade
Operating Expenses
947.33890.64708.19527.83483.83387.71
Upgrade
Operating Income
420.14429.2376.33242.59281.11273.85
Upgrade
Interest Expense
-98.02-95.03-78.48-42.77-13.93-1.8
Upgrade
Interest & Investment Income
7.376.899.2434.9732.1820.33
Upgrade
Currency Exchange Gain (Loss)
5.8110.8620.3125.49-18.17-3.96
Upgrade
Other Non Operating Income (Expenses)
2.19-2.87-1.28-1.47-1.25-1.6
Upgrade
EBT Excluding Unusual Items
337.49349.05326.11258.81279.96286.82
Upgrade
Gain (Loss) on Sale of Investments
-24.23-26.72-57.67-1.64-1.053.95
Upgrade
Gain (Loss) on Sale of Assets
0.130.240.03-5.510.15-0.01
Upgrade
Asset Writedown
-12.69-4.41-0.95--1.86-1.39
Upgrade
Other Unusual Items
-3.14-1.515.73-0.153.722.59
Upgrade
Pretax Income
297.02316.65273.26251.52280.9311.96
Upgrade
Income Tax Expense
14.6634.6432.9739.2349.0754.6
Upgrade
Earnings From Continuing Operations
282.36282.02240.29212.29231.83257.37
Upgrade
Minority Interest in Earnings
49.3443.0440.75---
Upgrade
Net Income
331.71325.06281.04212.29231.83257.37
Upgrade
Net Income to Common
331.71325.06281.04212.29231.83257.37
Upgrade
Net Income Growth
-0.78%15.66%32.39%-8.43%-9.92%80.58%
Upgrade
Shares Outstanding (Basic)
305304305304304304
Upgrade
Shares Outstanding (Diluted)
305304305307322306
Upgrade
Shares Change (YoY)
0.24%-0.36%-0.82%-4.47%5.00%23.77%
Upgrade
EPS (Basic)
1.091.070.920.700.760.85
Upgrade
EPS (Diluted)
1.091.070.920.690.720.84
Upgrade
EPS Growth
-1.02%16.08%33.48%-4.15%-14.21%45.89%
Upgrade
Free Cash Flow
184.09154.84-65.62151.17-183.3196.43
Upgrade
Free Cash Flow Per Share
0.600.51-0.210.49-0.570.32
Upgrade
Dividend Per Share
0.5000.5000.6510.2070.2370.237
Upgrade
Dividend Growth
-23.18%-23.18%214.29%-12.50%-200.00%
Upgrade
Gross Margin
32.08%31.34%30.28%30.73%32.29%32.01%
Upgrade
Operating Margin
9.86%10.19%10.51%9.68%11.87%13.25%
Upgrade
Profit Margin
7.78%7.72%7.85%8.47%9.79%12.45%
Upgrade
Free Cash Flow Margin
4.32%3.68%-1.83%6.03%-7.74%4.67%
Upgrade
EBITDA
617.19612.03597.06366.95379.29353.57
Upgrade
EBITDA Margin
14.48%14.53%16.67%14.64%16.01%17.11%
Upgrade
D&A For EBITDA
197.05182.83220.73124.3698.1879.72
Upgrade
EBIT
420.14429.2376.33242.59281.11273.85
Upgrade
EBIT Margin
9.86%10.19%10.51%9.68%11.87%13.25%
Upgrade
Effective Tax Rate
4.93%10.94%12.06%15.60%17.47%17.50%
Upgrade
Revenue as Reported
4,2624,2113,5822,5072,3692,067
Upgrade
Advertising Expenses
-12.177.811.7331.911.26
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.